Carl Zeiss Meditec AG
Company Profile
Business description
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEUT: +49 3641220115
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2025
Employees
5,730
Stocks News & Analysis
stocks
How I lost all my savings through a poor investment decision
stocks
Chart of the Week: Morningstar’s forecast for CSL’s future
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,063.40 | 33.90 | 0.38% |
CAC 40 | 7,784.76 | 42.69 | -0.55% |
DAX 40 | 23,457.54 | 209.27 | -0.88% |
Dow JONES (US) | 45,991.69 | 129.59 | -0.28% |
FTSE 100 | 9,222.64 | 27.79 | -0.30% |
HKSE | 26,484.68 | 33.97 | -0.13% |
NASDAQ | 22,293.45 | 204.40 | -0.91% |
Nikkei 225 | 45,754.93 | 124.62 | 0.27% |
NZX 50 Index | 13,153.79 | 27.52 | -0.21% |
S&P 500 | 6,597.51 | 40.46 | -0.61% |
S&P/ASX 200 | 8,773.00 | 35.10 | 0.40% |
SSE Composite Index | 3,853.30 | 0.34 | -0.01% |